API & intermediate

API
Project
CAS
Indications
State
Eltrombopag Olamine
Eltrombopag Olamine

496775-62-3

Treatment of aplastic anemia

Treat thrombocytopenia

Treating idiopathic thrombocytopenic purpura

Treatment of chronic hepatitis C

FDA Record No.: MF037269

Isaconazole sulfate
Isavuconazonium Sulfate

946075-13-4

Treat fungal infections

CDE Registration No.: Y20230000865

FDA Record No.: MF039193

Crisaborole
Crisaborole

906673-24-3

Treat atopic dermatitis

CDE Registration No.: Y20230000644

Elagolix Sodium
Elagolix Sodium

832720-36-2

Treatment of endometriosis

CDE Registration No.: Y20220000676

Phloroglucinol
Phloroglucinol

108-73-6

Alleviate acute spasmodic pain

CDE Registration No.: Y20220000230

Impurity table
Impurity name/code
CAS.No
chemical structure
Impurity name/code
CAS.No
chemical structure
P02-2Z9
/
P02-2Z9
P02-2Z10
/
P02-2Z10
P02-2Z11
/
P02-2Z11
P02-2Z12
/
P02-2Z12
P02-2Z13
/
P02-2Z13
P02-2Z14
2408053-56-3
P02-2Z14
P02-2Z15
761373-05-1
P02-2Z15
P02-2Z16
149709-63-7
P02-2Z16
Intermediates
Intermediate name
CAS.No
structural formula
Intermediate name
CAS.No
structural formula
3-噻吩羧酸, 5-(4-氨基苯基)-2-[[(2,6-二氟苯基)甲基](乙氧羰基)氨基]-4-[(二甲氨基)甲基]-乙酯盐酸盐
2768834-98-4
3-噻吩羧酸, 5-(4-氨基苯基)-2-[[(2,6-二氟苯基)甲基](乙氧羰基)氨基]-4-[(二甲氨基)甲基]-乙酯盐酸盐
2-[(2,6-二氟苄基)乙氧基羰基氨基]-4-甲基-5-(4-硝基苯基)噻吩-3-羧酸乙酯
308831-94-9
2-[(2,6-二氟苄基)乙氧基羰基氨基]-4-甲基-5-(4-硝基苯基)噻吩-3-羧酸乙酯
2-[(2 ,6-二氟苄基)乙氧基羰基氨基]-4-((二甲基氨基)甲基)-5-(4-硝基苯基)噻吩-3-甲酸乙酯
1589503-97-8
2-[(2 ,6-二氟苄基)乙氧基羰基氨基]-4-((二甲基氨基)甲基)-5-(4-硝基苯基)噻吩-3-甲酸乙酯
3-氨基-6-甲氧基哒嗪
7252-84-8
3-氨基-6-甲氧基哒嗪
2-((2,6-二氟苄基)(乙氧基羰基)氨基)-4-((二甲基氨基)甲基)-5-(4-硝基苯基)噻吩-3-羧酸
1589503-95-6
2-((2,6-二氟苄基)(乙氧基羰基)氨基)-4-((二甲基氨基)甲基)-5-(4-硝基苯基)噻吩-3-羧酸

Disclaimer: you confirm that these products cannot be supplied to countries where their use and / or commercialization may conflict with the existing intellectual property rights of third parties.